Cyclin D1 G870A polymorphism is a risk factor for esophageal cancer among asians

Cancer Investigation

Volumn 30, Issue 9, 2012, Pages 630-636

  Zhuo, Wenlei ^a   Zhang, Liang ^a   Wang, Yan ^a   Zhu, Bo ^a   Chen, Zhengtang ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

CCND1 G870A; Esophageal neoplasm; Meta analysis; Polymorphism; Susceptibility

Indexed keywords

CYCLIN D1;

ARTICLE; ASIAN; CANCER RISK; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; ESOPHAGUS CARCINOMA; ETHNIC DIFFERENCE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HISTOPATHOLOGY; HUMAN; PRIORITY JOURNAL; RISK ASSESSMENT; SYSTEMATIC REVIEW;

ASIA; ASIAN CONTINENTAL ANCESTRY GROUP; CYCLIN D1; ESOPHAGEAL NEOPLASMS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS;

EID: 84867712712     PISSN: 07357907     EISSN: 15324192     Source Type: Journal    
DOI: 10.3109/07357907.2012.726385     Document Type: Article

References (37)

1. Yao PF, Li GC, Li J, Xia HS, Yang XL, Huang HY, Fu YG, Wang RQ,Wang XY, Sha JW. Evidence of human papilloma virus infection and its epidemiology in esophageal squamous cell carcinoma. World J Gastroenterol 2006;12:1352-1325.
2. Tramacere I, La Vecchia C, Negri E. Tobacco smoking and esophageal and gastric cardia adenocarcinoma: a meta-analysis. Epidemiology 2011;22:344-349.
3. Islami F, Boffetta P, Ren JS, Pedoeim L, Khatib D, Kamangar F. High-temperature beverages and foods and esophageal cancer risk-a systematic review. Int J Cancer 2009;125:491-524.
4. MalikMA, Upadhyay R,Mittal RD, Zargar SA,Mittal B. Association of xenobiotic metabolizing enzymes genetic polymorphisms with esophageal cancer in Kashmir Valley and influence of environmental factors. Nutr Cancer 2010;62:734-742.
5. Wang Z, Hu J, Zhong J. Meta-analysis of the NAD(P)H: quinine oxidoreductase 1 gene 609 C>T polymorphism with esophageal cancer risk. DNA Cell Biol 2011;31(4):560-567.
6. Liu YX, Wang B, Wan MH, Tang WF, Huang FK, Li C. Metaanalysis of the relationship between the metholenetetrahydrofolate reductase C677T genetic polymorphism, folate intake and esophageal cancer. Asian Pac J Cancer Prev 2011;12:247-252.
7. Jiang DK, Yao L, Wang WZ, Peng B, Ren WH, Yang XM, Yu L. TP53 Arg72Pro polymorphism is associated with esophageal cancer risk: a meta-analysis. World J Gastroenterol 2011;17:1227-1233.
8. NiuY, YuanH, LengW, PangY, GuN, ChenN. CYP2E1Rsa I/Pst I polymorphism and esophageal cancer risk: a meta-analysis based on 1,088 cases and 2,238 controls. Med Oncol 2011;28:182-187.
9. Liu F, Li B, Wei Y, Chen X,Ma Y, Yan L, Wen T. P21 codon 31 polymorphism associated with cancer among white people: evidence from a meta-analysis involving 78,074 subjects. Mutagenesis 2011;26:513-521.
10. Zhao J, Li L, Wei S, Gao Y, Chen Y, Wang G, Wu Z. Clinicopathological and prognostic role of cyclin D1 in esophageal squamous cell carcinoma: a meta-analysis. Dis Esophagus 2011;25(6):520-526.
11. Saini SS, Klein MA. Targeting cyclin D1 in non-small cell lung cancer and mesothelioma cells by antisense oligonucleotides. Anticancer Res 2011;31:3683-3690.
12. Pabalan N, Bapat B, Sung L, Jarjanazi H, Francisco-Pabalan O, Ozcelik H. Cyclin D1 Pro241Pro (CCND1-G870A) polymorphism is associated with increased cancer risk in human populations: a meta-analysis. Cancer Epidemiol Biomarkers Prev 2008;17:2773-2781.
13. Lu F, Gladden AB, Diehl JA. An alternatively spliced cyclin D1 isoform, cyclin D1b, is a nuclear oncogene. Cancer Res 2003;63:7056-7061.
14. Solomon DA, Wang Y, Fox SR, Lambeck TC, Giesting S, Lan Z, Senderowicz AM, Conti CJ, Knudsen ES. Cyclin D1 splice variants. Differential effects on localization, RB phosphorylation, and cellular transformation. J Biol Chem 2003;278:30339-30347.
15. Munafo MR, Clark TG, Flint J. Assessing publication bias in genetic association studies: evidence from a recent meta-analysis. Psychiatry Res 2004;129:39-44.
16. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997;315:629-634.
17. Xing D, TanW, Lin D. Genetic polymorphisms and susceptibility to esophageal cancer among Chinese population (review). Oncol Rep 2003;10:1615-1623.
18. Gupta VK, Feber A, Xi L, Pennathur A, Wu M, Luketich JD, Godfrey TE. Association between CCND1 G/A870 polymorphism, allele-specific amplification, cyclin D1 expression, and survival in esophageal and lung carcinoma. Clin Cancer Res 2008;14:7804-7812.
19. Jain M, Kumar S, Upadhyay R, Lal P, Tiwari A, Ghoshal UC,Mittal B. Influence of apoptosis (BCL2, FAS), cell cycle (CCND1) and growth factor (EGF, EGFR) genetic polymorphisms on survival outcome: an exploratory study in squamous cell esophageal cancer. Cancer Biol Ther 2007;6:1553-1558.
20. Izzo JG, Wu TT, Wu X, Ensor J, Luthra R, Pan J, Correa A, Swisher SG, Chao CK, Hittelman WN, Ajani JA. Cyclin D1 guanine/adenine 870 polymorphism with altered protein expression is associated with genomic instability and aggressive clinical biology of esophageal adenocarcinoma. J Clin Oncol 2007;25:698-707.
21. Izzo JG, Malhotra U, Wu TT, Ensor J, Babenko IM, Swisher SG, Correa A, Bresalier RS, HittelmanWN, Ajani JA. Impact of cyclin D1 A870G polymorphism in esophageal adenocarcinoma tumorigenesis. Semin Oncol 2005;32:S11-S15.
22. Wang R, Zhang JH, Li Y, Wen DG, He M, Wei LZ. The association of cyclin D1 (A870G) polymorphism with susceptibility to esophageal and cardiac cancer in north Chinese population. Zhonghua Yi Xue Za Zhi 2003;83:1089-1092.
23. Zhang J, Li Y, Wang R, Wen D, SarbiaM, Kuang G, Wu M, Wei L, He M, Zhang L, Wang S. Association of cyclin D1 (G870A) polymorphism with susceptibility to esophageal and gastric cardiac carcinoma in a northern Chinese population. Int J Cancer 2003;105:281-284.
24. Hussain S, M Y, Thakur N, Salam I, Singh N, Mir MM, Bhat MA, Siddiqi MA, Das BC, Bharadwaj M. Association of cyclin D1 gene polymorphisms with risk of esophageal squamous cell carcinoma in Kashmir Valley: a high risk area. Mol Carcinog 2011;50:487-498.
25. Liu G, Cescon DW, Zhai R, Zhou W, KulkeMH,Ma C, Xu W, Su L,Asomaning K, HeistRS,Wain JC, Lynch TJ,ChristianiDC. p53 Arg72Pro, MDM2 T309G and CCND1 G870A polymorphisms are not associated with susceptibility to esophageal adenocarcinoma. Dis Esophagus 2010;23:36-39.
26. Jain M, Kumar S, Lal P, Tiwari A, Ghoshal UC, Mittal B. Role of BCL2 (ala43thr), CCND1 (G870A) and FAS (A-670G) polymorphisms in modulating the risk of developing esophageal cancer. Cancer Detect Prev 2007;31:225-232.
27. Geddert H,Kiel S, Zotz RB, Zhang J,Willers R, GabbertHE, Sarbia M. Polymorphism of p16 INK4A and cyclin D1 in adenocarcinomas of the upper gastrointestinal tract. J Cancer Res Clin Oncol 2005;131:803-808.
28. Casson AG, Zheng Z, Evans SC, Geldenhuys L, van Zanten SV, Veugelers PJ, Porter GA, Guernsey DL. Cyclin D1 polymorphism (G870A) and risk for esophageal adenocarcinoma. Cancer 2005;104:730-739.
29. Yu C, Lu W, Tan W, Xing D, Liang G, Miao X, Lin D. Lack of association between CCND1 G870A polymorphism and risk of esophageal squamous cell carcinoma.Cancer Epidemiol Biomarkers Prev 2003;12:176.
30. Kurmanov BK, Djansugurova L, Bersimbai R, Shibanova A, Yamashita S, Saenko V, Akulevich N. TP53 Arg72Pro and CCND1 A870G polymorphisms and esophageal cancer risk. J Life Sci 2010;4:16-20.
31. Tobias A. Assessing the influence of a single study in the metaanalysis estimate. Stata Techn Bull 1999;8:15-17.
32. Sergentanis TN, Economopoulos KP. Cyclin D1 G870A polymorphism and breast cancer risk: a meta-analysis comprising 9,911 cases and 11,171 controls. Mol Biol Rep 2011;38: 4955-4963.
33. Yuan L, Gu X, Shao J, Wang M, Zhu Q, Zhang Z. Cyclin D1 G870A polymorphism is associated with risk and clinicopathologic characteristics of bladder cancer. DNA Cell Biol 2010;29: 611-617.
34. Chen B, Cao L, Yang P, Zhou Y, Wu XT. Cyclin D1 (CCND1) G870A gene polymorphism is an ethnicity-dependent risk factor for digestive tract cancers: a meta-analysis comprising 20,271 subjects. Cancer Epidemiol 2011.
35. Zhang LQ, Wang J, Shang JQ, Bai JL, Liu FY, Guan X, Zhou JN. Cyclin D1 G870A polymorphism and colorectal cancer susceptibility: a meta-analysis of 20 populations. Int J Colorectal Dis 2011;26:1249-1255.
36. Ni J, Wang M, Fu S, Zhou D, Zhang Z, Han S. CCND1 G870A polymorphism and cervical cancer risk: a case-control study and meta-analysis. J Cancer Res Clin Oncol 2011;137:489-494.
37. Tang C, Wang Z, Yu J, Wu Y, Zhu Z, Chen N. CCND1 G870A polymorphismand risk for head and neck cancer: ameta-analysis. Med Oncol 2011;28:1319-1324.